Get the Stockscreener App
3.00
5.63%
0.16
Vivos Therapeutics Inc stock is traded at $3.00, with a volume of 48,185.
It is up +5.63% in the last 24 hours and up +20.97% over the past month.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
See More
Previous Close:
$2.84
Open:
$2.93
24h Volume:
48,185
Relative Volume:
0.44
Market Cap:
$16.08M
Revenue:
$14.58M
Net Income/Loss:
$-12.57M
P/E Ratio:
-0.5282
EPS:
-5.68
Net Cash Flow:
$-13.07M
1W Performance:
+9.89%
1M Performance:
+20.97%
6M Performance:
-2.91%
1Y Performance:
+36.99%
1-Day Range:
$2.76
$3.02
1-Week Range:
$2.50
$3.02
52-Week Range:
$1.91
$6.28
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Name
Vivos Therapeutics Inc
Sector
Industry
Phone
(866)908-4867
Address
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
3.00 | 16.08M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Vivos Therapeutics Inc Stock (VVOS) Latest News
Vivos Therapeutics Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - MSN
Geode Capital Management LLC Grows Stock Holdings in Vivos Therapeutics, Inc. (NASDAQ:VVOS) - Defense World
In brief: Revelstoke recaps AOM, Vivos to make buy, state legislation makes tracks - HME News
Vivos Therapeutics to acquire operating assets of The Sleep Center of Nevada - MSN
Healthcare Stocks Take A Hit Despite Abbott's Earnings Beat - Finimize
Vivos Therapeutics to Acquire The Sleep Center of Nevada - marketscreener.com
Vivos Opens New Sleep Center - Baystreet.ca
Vivos Therapeutics announces agreement to acquire operating assets of SCN - TipRanks
Vivos To Acquire Operating Assets Of The Sleep Center Of Nevada - Nasdaq
Vivos Therapeutics Signs Definitive Agreement To Acquire Largest Sleep Center Operator In Nevada - marketscreener.com
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada - The Manila Times
Major Healthcare Expansion: Vivos Takes Over Nevada Sleep Giant Serving 3,000 Monthly Patients - Stock Titan
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Report on Q2 2024 Financial Results, Operational Update - MSN
Commonwealth Equity Services LLC Buys 5,000 Shares of Vivos Therapeutics, Inc. (NASDAQ:VVOS) - Defense World
Positive Sentiment Still Eludes Vivos Therapeutics, Inc. (NASDAQ:VVOS) Following 26% Share Price Slump - simplywall.st
Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress - ACCESS Newswire
Vivos Therapeutics Inc (VVOS) Q4 2024 Earnings Call Highlights: Strategic Shifts Propel Revenue ... By GuruFocus - Investing.com Canada
Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates - MSN
Vivos Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance
Vivos Therapeutics’ Earnings Call Highlights Growth and Expansion - TipRanks
Vivos Therapeutics (VVOS) Grows Revenue by 26% and Cuts Operatin - GuruFocus
Vivos Therapeutics price target lowered to $5.50 from $6 at Alliance Global Partners - TipRanks
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2024 Earnings Call Transcript - Insider Monkey
Vivos Therapeutics Reports Revenue Growth and Strategic Shift - TipRanks
Vivos Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Vivos Therapeutics Q4 2024 revenue rises 9% By Investing.com - Investing.com UK
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update - TradingView
Vivos Earnings: Revenue Jumps 9% as FDA Approves Game-Changing Pediatric Sleep Apnea Treatment - Stock Titan
Vivos Therapeutics Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Sees Large Decline in Short Interest - Defense World
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call - The Manila Times
Medical Device Innovator Vivos Sets Key Earnings Date: What to Watch in 2024 Results - Stock Titan
Analyzing Vivos Therapeutics (NASDAQ:VVOS) and Alpha Tau Medical (NASDAQ:DRTS) - Defense World
The Silent Epidemic: How Women With Obstructive Sleep Apnea (OSA) Are Often Misdiagnosed - Yahoo Finance
Vivos Therapeutics (VVOS) Projected to Post Quarterly Earnings on Thursday - Defense World
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Short Interest Update - Defense World
Vivos Drives Innovation in Chronic Pain Care with Non-Invasive Treatment for Sleep Apnea - PRWeb
Anti-Snoring Devices Markets: Oral Appliances, Nasal - GlobeNewswire
Anti-Snoring Devices Markets: Oral Appliances, Nasal Devices, Position Control DevicesGlobal Forecast to 2029 with ResMed, SomnoMed, ProSomnus, and Vivos Therapeutics, and DynaFlex Dominating - Yahoo Finance UK
Comparing Vivos Therapeutics (NASDAQ:VVOS) and Regenicin (OTCMKTS:RGIN) - Armenian Reporter
Vivos Therapeutics Announces the Opening of the First Pneusomnia Integrated Medical-Dental Sleep Center - marketscreener.com
Vivos Explores ‘Outright Acquisitions of Sleep Centers’ - Sleep Review
Vivos Therapeutics sees strong adoption of OSA treatment, expands strategic alliance - Proactive Investors UK
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide - The Manila Times
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and - EIN News
Reviewing Vivos Therapeutics (NASDAQ:VVOS) & Biostage (OTCMKTS:BSTG) - Defense World
Vivos Therapeutics Inc Stock (VVOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):